Journals / Klinik Psikofarmakoloji Bülteni / 2011 / Cilt: 21 - Sayı: 3

Travma sonrası stres bozukluğunda amitriptilin ve paroksetinin etkinliği: Açık etiketli karşılaştırmalı çalışma

Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study

Pages
179–185
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When we look at the changes in symptom patterns in terms of CAPS 2 scores, it was found that amitriptyline have decreased intrusive and increased arousal symptoms more than paroxetine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the efficacy of amitriptyline and paroxetine in soldiers with combat-related post traumatic stress disorder (PTSD).
📊
Key Findings & Data:The primary outcome measures for the study was 17-item total severity score of the Clinician-Administered PTSD Scale (CAPS), Investigator-rated Clinical Global Impression (CGI-S) and CGI Improvement Scales (CGI-I).
💡
Conclusion & Impact:When we look at the changes in symptom patterns in terms of CAPS 2 scores, it was found that amitriptyline have decreased intrusive and increased arousal symptoms more than paroxetine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the efficacy of amitriptyline and paroxetine in soldiers with combat-related post traumatic stress disorder (PTSD). Method: Fifty patients who were admitted to Gülhane Military Medical Academy Psychiatry Inpatient Clinic and who were diagnosed as chronic PTSD were enrolled. The primary outcome measures for the study was 17-item total severity score of the Clinician-Administered PTSD Scale (CAPS), Investigator-rated Clinical Global Impression (CGI-S) and CGI Improvement Scales (CGI-I). Patients were randomized to 12 weeks of treatment with either paroxetine (25 patients) or amitriptyline (25 patients). Twenty-two patients from paroxetine group and 20 patients from amitriptyline group completed the study protocol. Results: Treatment response rates for paroxetine and amitriptyline was 31.8% and 55%, respectively. While there was a significant difference for CAPS-2 total score changes between the groups, no statistically significant difference was found for CGI severity, CGI progress, change in depression and anxiety scores. Conclusions: Both amitriptyline and paroxetine seem to be effective in the treatment of combat related PTSD cases. Despite no statistically significant difference between both groups, treatment response with amitriptyline seems to be higher. When we look at the changes in symptom patterns in terms of CAPS 2 scores, it was found that amitriptyline have decreased intrusive and increased arousal symptoms more than paroxetine.

Özet

Amaç: Bu çalışmanın amacı çatışma ile ilişkili Travma Sonrası Stres Bozukluğu (TSSB) olan askerlerde amitriptilin ve paroksetinin etkinliğini değerlendirmektir. Yöntem: Çalışmaya Gülhane Askeri Tıp Akademisi Psikiyatri Servisinde yatan, kronik nitelik kazanmış TSSB tanısı konulan 50 hasta alındı. Primer ölçümler Clinician Administered Post Traumatic Stress Disorder Scale (CAPS), Klinik Genel İzlenim-Şiddet Ölçeği (CGI-S) ve Klinik Genel İzlenimİyileşme Ölçeği (CGI-I) ile yapıldı. Hastalar tedavi gruplarına (25 hasta paroksetin, 25 hasta amitiriptilin) rasgele seçildi ve 12 haftalık tedavi protokolüne alındılar. Paroksetin grubundan 22, amitriptilin grubundan 20 hasta çalışma protokolünü tamamladı. Bulgular: Paroksetin ve amitriptilin tedavisi yanıt oranları sırasıyla % 31.8 ve% 55 idi. Gruplar arasında CAPS toplam puanı değişimlerinde anlamlı bir fark var iken, anksiyete ve depresyon puanlarındaki değişim, CGI-şiddet ve CGIilerleme için fark bulunmadı. Sonuç: Çatışma ile ilişkili TSSB olgularının tedavisinde hem paroksetin hem de amitriptilinin etkili olduğu söylenebilir. İki grup arasında istatistiksel bir fark olmamakla birlikte amitriptilin ile tedavi cevabı daha yüksek olma eğilimindedir. CAPS 2 belirti kümeleri açısından bakıldığında amitriptilinin intruziv belirtiler ve aşırı uyarılma belirtilerini daha fazla azalttığı görülmektedir.

🔖

Cite This Article

ÖZNUR, T., ÖZMENLER, K. N., YELBOGA, Z., BALİKCİ, A., ÇELİK, C., DORUK, A., BOZKURT, A., ÖZDEMİR, B. (2022). Travma sonrası stres bozukluğunda amitriptilin ve paroksetinin etkinliği: Açık etiketli karşılaştırmalı çalışma. Klinik Psikofarmakoloji Bülteni, Cilt: 21 - Sayı: 3, 179–185. https://ajindex.com/articles/574151

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
  2. Washington, DC, American Psychiatric Association. 1994 2. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52(12):1048-60. 3. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 1993; 61(6):984-91. 4. Kulka RA, Schlenger WE, Fairbank JA, Hough RL, Jordan BK, Weiss DS. Trauma and the Vietnam War generation: report of findings from the National Vietnam Veterans Readjustment Study. New York, Brunner/Mazel. 1990 5. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990; 47(3):259–66. 6. Frank JB, Kosten TR, Giller EL Jr, Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 1988; 145(10):1289-91. 7. Kosten TR, Frank JB, Dan E, McDougole CJ, Giller EL. Pharmacotherapy for posttraumatic stress disorder using phenalzine an imipramine. J Nerv Ment Dis 1991; 179(6):366-70. 8. Reist C, Kauffmann CD, Haier RJ, Sangdahl C, DeMet EM, Chicz- DeMet A, et al. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989; 146(4):513-6. 9. Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 1988; 24(2):149-55. 10. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994; 55(12):517-22. 11. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 2000; 12(2):101-5. 12. Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu R, et al. Open trial of fluvoxamine treatment for combatrelated posttraumatic stress disorder. J Clin Psychiatry Suppl 1996; 57(8):66–70. 13. Kline NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder. Am J Psychiatry 1994; 151(4):621. 14. Shay J. Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with PTSD. J Trauma Stress 1992; 5(1):97–101. 1